Chemours Company
(CC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 1,730,000 | 1,574,000 | 1,584,000 | 1,588,000 | 1,437,000 |
| Cost of Goods | 1,193,000 | 1,088,000 | 1,119,000 | 1,150,000 | 1,081,000 |
| Gross Profit | 537,000 | 486,000 | 465,000 | 438,000 | 356,000 |
| Operating Expenses | 173,000 | 211,000 | 181,000 | 191,000 | 181,000 |
| Operating Income | 364,000 | 275,000 | 284,000 | 247,000 | 175,000 |
| Interest Expense | 52,000 | 54,000 | 55,000 | 54,000 | 51,000 |
| Other Income | 69,000 | 43,000 | 21,000 | 32,000 | 49,000 |
| Pre-tax Income | 381,000 | 264,000 | 250,000 | 225,000 | 173,000 |
| Income Tax | 84,000 | 36,000 | 43,000 | 64,000 | 22,000 |
| Net Income Continuous | 297,000 | 228,000 | 207,000 | 161,000 | 151,000 |
| Minority Interests | N/A | N/A | N/A | N/A | 1,000 |
| Net Income | $297,000 | $228,000 | $207,000 | $161,000 | $150,000 |
| EPS Basic Total Ops | 1.63 | 1.23 | 1.12 | 0.87 | 0.82 |
| EPS Basic Continuous Ops | 1.63 | 1.23 | 1.12 | 0.87 | 0.82 |
| EPS Diluted Total Ops | 1.58 | 1.20 | 1.08 | 0.84 | 0.79 |
| EPS Diluted Continuous Ops | 1.58 | 1.19 | 1.08 | 0.84 | 0.80 |
| EBITDA(a) | $437,000 | $347,000 | $349,000 | $322,000 | $249,000 |